Friday, November 17, 2006

Kill your project ASAP

This month Nature Reviews Drug Discovery contains an article about Tufts CSDD Impact Report. Bayer, AstraZeneca, Allergan, Boehringer Ingelheim and Merck turn out to be the speed-demons of pharmaceutical industry.

"These five companies, according to the report "deliver as much as a 17-month speed advantage over average performers"."

The reason is clear why other are so slow.

"Decisions still tend to be made at the highest possible level, which means decision-makers have less insight into what people are working on. Project teams go to the decision-makers fighting for their compounds as much as possible, and are reluctant to give up on their project, in the hope that a project will succeed through perseverance. This makes it easy for projects to run beyond the point where the team knows they are not going to work."

Wow.. What a conclusion… We all knew that already. This is how it works in all industries, and in politics as well.

No comments: